Top Markets
Coin of the day
Zylox-Tonbridge Medical Technology Co., Ltd. Zylox-Tonbridge Medical Technology Co., Ltd.

Zylox-Tonbridge Medical Technology Co., Ltd.

2190
Rangering i aksjer #10235
Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm... Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters for treating arterial stenoses or blockages in these same regions. Their neurovascular offerings further extend to Ton-Bridge extra soft coils, utilized for the endovascular embolization of intracranial aneurysms and other cerebral vascular malformations like arteriovenous malformations (AVMs) and fistulae. Supporting these are a range of microcatheters (for coiling or selective agent delivery), distal access and intracranial PTA balloon catheters, vascular snares, and IVC filter snare retrieval kits. Established in 2012, Zylox-Tonbridge Medical Technology Co., Ltd. maintains its headquarters in Zhejiang, People's Republic of China.
Aksjekurs
$2.80
Sist synkronisert: 2026-08-28
Markedsverdi
$869.04M
Endring (1 dag)
-0.36%
Endring (1 år)
-5.19%
Land
CN
Handel Zylox-Tonbridge Medical Technology Co., Ltd. (2190)

Kategori

Antall utestående aksjer for Zylox-Tonbridge Medical Technology Co., Ltd. (2190)
Antall utestående aksjer per August 2026: 0
Ifølge Zylox-Tonbridge Medical Technology Co., Ltd. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Zylox-Tonbridge Medical Technology Co., Ltd. (2190) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
1.74B -
US
383.50M -
US
1.28B -
IE
1.48B -
US
- -
DE